NCT01204619

Brief Summary

Since the emergence of home peritoneal dialysis as an alternative to in-center hemodialysis for chronic renal replacement therapy in the late 1970s, the percentage of dialysis patients on PD has continued to decrease each year. There have been a growing concern and research on patient and technique survival of peritoneal dialysis versus hemodialysis to find influential factors for better clinical outcomes. Meanwhile, technique failure rates were significantly higher in small centers treating less than twenty five PD patients. And there was a result for better technique survival after the second year, among the patients trained at the BREC(Baxter Renal Education Center). Better technique survival in large centers can be assumed with not only their more experience with patient management but also their educational infrastructure compared to small-sized centers. Throughout our experiences in the last 30 years, we have recognized that a major element of PD program is patient training, however few data are available in terms of the relationship between PD training and treatment outcome and mostly are retrospective and non-randomized. Moreover, the technique survival and patient survival were analyzed with no significant difference. From the insight, we decided to study prospectively to evaluate the efficacy of well-structured education program in terms of various patient outcomes in incident patients on PD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 16, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 17, 2010

Completed
3 months until next milestone

Study Start

First participant enrolled

December 1, 2010

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

April 14, 2016

Status Verified

April 1, 2016

Enrollment Period

4.6 years

First QC Date

September 16, 2010

Last Update Submit

April 12, 2016

Conditions

Keywords

peritoneal dialysis

Outcome Measures

Primary Outcomes (1)

  • Exit site infection

    24 months

Secondary Outcomes (23)

  • time to the first peritonitis

    24 months

  • Number of ESIs per patient-month

    24 months

  • Days of hospitalization per year

    24 months

  • Systolic pressure and diastolic pressure measured at every visit

    24 months

  • Average number of antihypertensive medications

    24 months

  • +18 more secondary outcomes

Study Arms (2)

Conventional training group

NO INTERVENTION

in-center conventional training programs + two home visits

Intensive training group

EXPERIMENTAL

in-center conventional training programs + an extra structured patient home visits repeatedly and regularly

Behavioral: Intensive training group

Interventions

an extra structured patient centric training program on PD technique and diet according to the developed training curriculum

Intensive training group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Incident patients who have PD catheter insertion for starting PD with Baxter solutions
  • \> 20 yr of age

You may not qualify if:

  • Patients who are likely to receive kidney transplant or shift to hemodialysis within the following 1 year
  • Patients diagnosed with acute inflammatory disease for the past three months
  • Patients currently diagnosed with chronic inflammatory disease
  • Currently pregnant or breastfeeding
  • Patients who are involved in other clinical trial within 30 days prior to enrollment
  • Patients who are currently hospitalized in care facilities such as nursing home, etc., or those who are expected to be hospitalized for the duration of the clinical test
  • Patients who cannot perform PD by themselves
  • Patients considered by the person in charge of the clinical test to have difficulty in participating in this clinical test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Wonkwang University, Sanbon Medical Center

Gunpo, Gyeonggi-do, South Korea

Location

Hallym University Sacred Hospital Puyngchon

Anyang, South Korea

Location

Gachon University Gil Hospital

Incheon, South Korea

Location

Eulji Medical Center

Seoul, South Korea

Location

Hallym University Sacred Hospital Gangdong

Seoul, South Korea

Location

Seoul National University Hospital

Seoul, South Korea

Location

MeSH Terms

Conditions

Risk Reduction Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Kook-Hwan Oh, M.D., PhD

    Seoul National University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 16, 2010

First Posted

September 17, 2010

Study Start

December 1, 2010

Primary Completion

July 1, 2015

Study Completion

March 1, 2016

Last Updated

April 14, 2016

Record last verified: 2016-04

Data Sharing

IPD Sharing
Will not share

Locations